Rivabazumab is a recombinant monoclonal antibody specifically targeting the PcrV protein of Pseudomonas aeruginosa. This antibody is designed for the precise detection and neutralization of the PcrV component, which plays a critical role in the pathogenicity of Pseudomonas aeruginosa by facilitating the injection of toxic effector proteins into host cells. Rivabazumab is utilized extensively in research focused on bacterial infection mechanisms, vaccine development, and therapeutic interventions against Pseudomonas aeruginosa.
Rivabazumab is a recombinant monoclonal antibody specifically targeting the PcrV protein of Pseudomonas aeruginosa. This antibody is designed for the precise detection and neutralization of the PcrV component, which plays a critical role in the pathogenicity of Pseudomonas aeruginosa by facilitating the injection of toxic effector proteins into host cells. Rivabazumab is utilized extensively in research focused on bacterial infection mechanisms, vaccine development, and therapeutic interventions against Pseudomonas aeruginosa.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
